» Articles » PMID: 852498

First Pass Hydroxylation of Nortriptyline: Concentrations of Parent Drug and Major Metabolites in Plasma

Overview
Specialty Pharmacology
Date 1977 Mar 11
PMID 852498
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Nortriptyline was given orally and intramuscularly to six depressed patients. Plasma concentrations of parent drug and the unconjugated and conjugated principal metabolite, 10-hydroxynortriptyline, were determined by mass fragmentography. There was a significant decrease in the area under the nortriptyling plasma concentration- time curve after the oral route of administration, whilst the elimination rate was unchanged. With the oral dose, plasma concentrations of the metabolites were higher and peaked earlier than after intramuscular administration, whilst the opposite was true for the parent compound. This proves that the difference in bioavailability between the two routes of administration was due to first pass metabolism. As determined from the ratio between corresponding areas, the relative bioavailability of the oral dose was 66 +-21 S.D. per cent. This fraction is higher than that reported previously when intravenous nortriptyline was used as the reference dosage form.

Citing Articles

The Role of Metabolites of Antidepressants in the Treatment of Depression.

Rudorfer M, Potter W CNS Drugs. 2016; 7(4):273-312.

PMID: 27520753 DOI: 10.2165/00023210-199707040-00003.


Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

de Leede L, De Boer A, Feijen C, Breimer D Pharm Res. 2013; 1(3):129-34.

PMID: 24277250 DOI: 10.1023/A:1016380104424.


Quantitative pharmacogenetics of nortriptyline: a novel approach.

Kvist E, Al-Shurbaji A, Dahl M, Nordin C, Alvan G, Stahle L Clin Pharmacokinet. 2001; 40(11):869-77.

PMID: 11735606 DOI: 10.2165/00003088-200140110-00005.


Metabolism of tricyclic antidepressants.

Rudorfer M, Potter W Cell Mol Neurobiol. 1999; 19(3):373-409.

PMID: 10319193 PMC: 11545471. DOI: 10.1023/a:1006949816036.


Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Furlanut M, Benetello P, Spina E Clin Pharmacokinet. 1993; 24(4):301-18.

PMID: 8491058 DOI: 10.2165/00003088-199324040-00004.


References
1.
Perrier D, Gibaldi M . Clearance and biologic half-life as indices of intrinsic hepatic metabolism. J Pharmacol Exp Ther. 1974; 191(1):17-24. View

2.
Harris P, RIEGELMAN S . Influence of the route of administration on the area under the plasma concentration-time curve. J Pharm Sci. 1969; 58(1):71-5. DOI: 10.1002/jps.2600580114. View

3.
Alvan G, Lind M, Mellstrom B, von Bahr C . Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol. J Pharmacokinet Biopharm. 1977; 5(3):193-205. DOI: 10.1007/BF01065395. View

4.
SHAND D, Nuckolls E, OATES J . Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970; 11(1):112-20. DOI: 10.1002/cpt1970111112. View

5.
Rowland M . Influence of route of administration on drug availability. J Pharm Sci. 1972; 61(1):70-4. DOI: 10.1002/jps.2600610111. View